Renal Tubulocystic Carcinoma Is Closely Related to Papillary Renal Cell Carcinoma: Implications for Pathologic Classification
Authors:
- Ming ZhouMZMing Zhou
- Ximing J. YangXYXiming J. Yang
- Jose I. LopezJLJose I. Lopez
- Rajal B. ShahRSRajal B. Shah
- Ondrej HesOHOndrej Hes
- Steven S. ShenSSSteven S. Shen
- Rongshan LiRLRongshan Li
- Yu YangYYYu Yang
- Fan LinFLFan Lin
- Paul ElsonPEPaul Elson
- Linda SerciaLSLinda Sercia
- Cristina Magi-GalluzziCMCristina Magi-Galluzzi
- 1 December 2009
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 33 (12) , 1840-1849
Abstract
Tubulocystic carcinoma of the kidney (TC-RCC) is a rare renal tumor with unique gross and microscopic features unlike other types of renal cell carcinoma (RCC). Several recent studies recommend that it should be classified as a distinct RCC subtype. In this study, we provide pathologic and cytogenetic evidence supporting that TC-RCC is closely related to papillary RCC (PRCC). This study included 20 cases of renal tumors that partially or exclusively comprised a TC-RCC component. Pathologic examination documented the gross and microscopic features of TC-RCC, including multicentricity and the presence of concomitant PRCC and papillary adenoma. Formalin-fixed, paraffin-embedded sections from 12 TC-RCC and 20 PRCC were subjected to a multicolor fluorescence in situ hybridization assay containing probes for chromosomes 7, 17, and Y. One hundred nuclei were examined to enumerate the copy numbers of chromosomes in each tumor and its corresponding normal kidney tissue. A tumor with a percentage of cells harboring a chromosomal change ≥mean+3 SD of normal tissue was considered to harbor that chromosomal change, and a tumor with a percentage of cells with null Y chromosome count (loss of Y chromosome) ≥mean+3 SD of normal tissue was considered to harbor Y chromosome loss. Four of the 20 TC-RCCs were multicentric. Ten had associated PRCC or papillary adenoma within the same kidney as the TC-RCC. In 4 cases, the tubulocystic and papillary components were admixed together within the same lesion. The tumor cells lining both the tubulocystic and papillary components had similar cytologic features. Ten of 12 TC-RCCs had a chromosome 7 gain, 8 of 12 cases had a chromosome 17 gain, and 8 of 9 cases had a loss of Y chromosome. Six of 9 cases with all 3 chromosomes studied had a gain of chromosomes 7 and 17 and a loss of Y chromosome. Our study shows that TC-RCCs and PRCCs are closely related entities. With its distinctive gross and microscopic features, TC-RCC may be considered a unique “morphologic entity.” However, before it is accepted as a distinct renal cell carcinoma subtype, further studies are needed to document a characteristic molecular signature associated with this tumor.Keywords
This publication has 20 references indexed in Scilit:
- Tubulocystic Carcinoma of the KidneyAmerican Journal of Surgical Pathology, 2009
- Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasmsHuman Pathology, 2009
- Clear Cell Papillary Renal Cell CarcinomaAmerican Journal of Surgical Pathology, 2008
- Tubulocystic carcinoma of the kidney: a new entity among renal tumorsVirchows Archiv, 2007
- Tubulocystic Carcinoma, Mucinous Tubular and Spindle Cell Carcinoma, and Other Recently Described Rare Renal TumorsClinics In Laboratory Medicine, 2005
- Robust Classification of Renal Cell Carcinoma Based on Gene Expression Data and Predicted Cytogenetic ProfilesCancer Research, 2004
- Gene Expression Patterns in Renal Cell Carcinoma Assessed by Complementary DNA MicroarrayThe American Journal of Pathology, 2003
- Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct originUrology, 1997
- Chromosomal findings andp53-mutation analysis in chromophilic renal-cell carcinomasInternational Journal of Cancer, 1996
- Papillary Renal Cell CarcinomaDiagnostic Molecular Pathology, 1996